Assessment of the impact of environmental chemicals on androgen homeostasis in rodent models is confounded by high intraindividual and interindividual variability in circulating testosterone levels. Our goal was to evaluate changes in testosterone biotransformation processes as a measure of androgen homeostasis and as a biomarker of exposure to androgen-disrupting chemicals. Sexspecific differences in hepatic testosterone biotransformation enzyme activities were identified in CD-i mice. Gonadectomy followed by replacement of individual steroid hormones identified specific sex differences in biotransformation profiles that were due to the inductive or suppressive effects of testosterone. Notably, significant androgen-dependent differences in testosterone 6a-and 15a-hydroxylase activities were demonstrated, and the ratio of 6w and 15a-hydroxylase activities proved to be an excellent indicator of the androgen status within the animaL The male or "masculinized" testosterone 6alotISt-hydroxylase ratio was significantdy less than the female or "feminized" ratio. Male mice were exposed to both an antiandrogen, vinclozolin, and to a compound that modulates serum androgen levels, indole-3-carbinol, to test the utility of this ratio as a biomarker of androgen disruption. Treatment with the antiandrogen vinclozolin significantly increased the 6ax1l5a-hydroxylase ratio. Indole-3-carbinol treatment resulted in a dose-dependent, but highly variable, decrease in serum testosterone levels. The 6aIlSa-hydroxylase ratio increased as serum testosterone levels decreased in these animals. However, the increase in the ratio was much less variable and more sensitive than serum testosterone levels. These investigations demonstrate that the 6a/150-hydroxylase ratio is a powerfil measure of androgen modulation and a sensitive indicator of exposure to androgen-disrupting chemicals in CD-1 mice. Key work androgen disruption,.biomarker, biotransformation, sexually dimorphic metabolism, testosterone.
increased the 6ax1l5a-hydroxylase ratio. Indole-3-carbinol treatment resulted in a dose-dependent, but highly variable, decrease in serum testosterone levels. The 6aIlSa-hydroxylase ratio increased as serum testosterone levels decreased in these animals. However, the increase in the ratio was much less variable and more sensitive than serum testosterone levels. These investigations demonstrate that the 6a/150-hydroxylase ratio is a powerfil measure of androgen modulation and a sensitive indicator of exposure to androgen-disrupting chemicals in CD-1 mice. Key work androgen disruption,.biomarker, biotransformation, sexually dimorphic metabolism, testosterone. Environ Heah Pepect 107:377-384 (1999). [Online 2 April 1999] http://ehpnet1.niehs.nih.gov/docs/ 9,99/107p377-384wikon/abstract.htmI Maintenance of steroid hormone homeostasis within an organism is critical to ensuring male and female sexual functions, including sexual differentiation and reproduction (1) . Steroid hormones play a decisive role in sexual differentiation of the gonads and accessory reproductive organs occurring during prenatal and neonatal development (2) . In addition, steroid hormones influence the acquisition and maintenance of secondary sex characteristics in adults (3) . Recently, concern has been raised that both humans and wildlife are being exposed to endocrinedisrupting chemicals in the environment and that these compounds may be eliciting adverse effects on development and fertility along with contributing to the increasing rates of certain types of cancers (4) (5) (6) (7) (8) (9) . Recent clinical observations including increased incidence of male genital tract malformations, (10) (11) (12) (13) , reductions in sperm count (14) , and increased incidence of testicular (15, 16) , prostate (17) , and breast cancer (16, 18) have been suggested to be linked to exposure to these chemicals. Speculation remains as to whether human health issues are associated with the existence of endocrine-disrupting chemicals in the environment (16, (18) (19) (20) . However, concerns connected with hormone-related health problems in humans along with good evidence in wildlife of endocrine disruption (21, 22) , a growing knowledge base of hormonally active chemicals (23) , and wellcontrolled experiments demonstrating developmental effects in model organisms consistent with those seen in humans and wildlife (9, (24) (25) (26) have led Congress to pass two pieces of legislation that mandate the design of testing programs to identify endocrine-disrupting chemicals.
Several studies have suggested that toxicant-induced alterations in steroid hormone levels or metabolism contribute to reproductive impairment and that changes in steroid hormone levels can be indicative of endocrine-disrupting chemical exposure (27) (28) (29) (30) . However, in many commonly used and widely accepted rodent models, the utility of the measurement of circulating serum hormone levels alone as an indicator of exposure to androgen-disrupting chemicals is limited. In male laboratory mice and males of several other species, including humans, there is striking intraindividual and interindividual variability in testosterone levels (31) (32) (33) (34) . Thus, it is extremely difficult to detect statistically significant differences in steroid hormone levels due to exposure to a xenobiotic. Subtle disturbances in homeostatic mechanisms by a xenobiotic may go undetected until more profound irreversible effects are manifested. This toxicity is especially insidious during sex differentiation and development because of the critical role of gonadal steroid hormones in regulating these processes. A more sensitive biomarker of androgen disruption due to chemical exposure is needed.
The hepatic cytochrome P450-dependent monooxygenase system (P450) plays a central role in metabolism. This system is not only important in the detoxification of foreign compounds but also is responsible for the oxidative metabolism of endogenous substrates such as steroid hormones (35) (36) (37) (38) . Despite their broad substrate specificity, however, P450 isozymes hydroxylate testosterone in a characteristic and unique manner that is both region specific and stereospecific (39) . Modulation of individual hepatic steroid hydroxylase activities by hormones (40, 41) and sex-dependent expression of hepatic steroid metabolizing enzymes in rat is well-established (42) .
In addition to hydroxylation, direct conjugation is a second major route of metabolism (1) . Uridine diphosphate (UDP)-glucuronosyltransferase or sulfotransferase enzymes can conjugate glucuronic acid or sulfate, respectively, to testosterone either directly or subsequent to hydroxylation. These reactions generally produce more water-soluble compounds that can then be excreted in urine (43) . Some studies have suggested sexually dimorphic UDP-glucuronosyltransferase activity in humans and in mice, but results from other studies in humans have not supported these observations (49, 50) . A possible explanation for these conflicting results may be that, because multiple isoforms of UDP-glucuronosyltransferase enzymes exist (51, 52) , some may be affected by sex while others are not. Sulfotransferase enzymes are also expressed in multiple forms, and there is evidence that their expression can be modulated by steroid hormones (53) .
In this study, we hypothesized that changes in androgen-regulated testosterone biotransformation processes in CD-1 mice could be used as a sensitive biomarker of exposure to some endocrine-disrupting chemicals. The primary goals of this study were to 1) identify specific sex differences in constitutive steroid biotransformation activities in the CD-1 mouse model; 2) determine the role of androgens in the regulation of these activities; 3) identify an activity that might best serve as a biomarker of exposure to androgen-disrupting chemicals; and 4) validate this biomarker using organisms exposed to xenobiotics that either act as androgen antagonists or modulate endogenous androgen levels.
Materials and Methods
Animals. Eight-week-old adult male and female CD-1 mice (sexually intact animals, sham-operated controls, and gonadectomized animals) were purchased from Charles River Laboratories (Raleigh, NC, or Portage, ME). Sham-operated, gonadectomized, and respective control mice designated for hormonal regulation experiments were allowed a 2-week recovery period after surgery at our facility before implantation of hormone pellets. All other mice were held at our animal facility for at least 1 Pellets were implanted subcutaneously below the right scapula using a trochar; the incisions were closed with surgical clamps. On the morning of the twenty-first day after implantation, mice were euthanized by CO, asphyxiation. Blood was collected and the livers were rapidly excised, quick frozen in liquid nitrogen, and then stored at -800C until microsomes were prepared. Absence of testes or ovaries in gonadectomized animals was confirmed by visual inspection. (56) . Cytosolic supernatant was reserved, microsomal pellets were resuspended in buffer (0.1 M potassium phosphate, pH 7.4, 0.1 mM EDTA, and 20% glycerol), and both were stored at -80°C until assays were performed. Protein concentrations were determined using commercially prepared reagents (Biorad, Hercules, CA) and bovine serum albumin (Sigma) as a standard.
Testosterone hydroxylase assays. Testosterone hydroxylase activities in mouse livers were assayed as previously described (38, 58) (48, 58) . In untreated animals, total testosterone hydroxylase activity was comparable in both sexes; however, isolation and quantification of individual hydroxylated testosterone metabolites revealed sex-specific differences in the production rates of at least two of these metabolites (48) . As illustrated in Figure 1 , hepatic testosterone 6a-hydroxylase (6a-OH) activity was consistently higher in female mice than in male mice. Conversely, testosterone 15ax-hydroxylase (1 5a-OH) activity was consistently higher in male mice (Fig. 1) . Our results also showed that the constitutive rate of specific activity of UDP-glucuronosyltransferase was higher in hepatic microsomes from male mice, whereas sulfotransferase activity was consistently higher in hepatic cytosol from females (Fig. 1) . These consistent differences in testosterone biotransformation between males and females indicate a possible regulatory role for gonadal steroid hormones in one or more of these activities.
Gonadectomy and hormone replacement experiments: testosterone. The effects of gonadectomy and subsequent testosterone replacement on 6a-and 1 5a-hydroxylase activities and on UDP-glucuronosyltransferase and sulfotransferase conjugations are shown in Figures 2 and 3 (Fig. 3) . UDPGlucuronosyltransferase activity was significantly reduced in gonadectomized males (Fig. 3A) mice from these testosterone modulation experiments. The ratio of 6ca/15a-hydroxylase activity was significantly higher in normal adult females than in untreated adult male mice, and better differentiated the masculine and feminine metabolic profile as compared to individual hydroxylase activities. Further, the coefficients of variation for the 6W/1S5a-hydroxylase ratio were much lower than for serum testosterone levels.
These results indicated that the 6oa/15ct-hydroxylase ratio was a good measure of androgen status and may serve as a more sensitive biomarker of androgen disruption than measurement of serum testosterone levels alone. The role that the other gonadal steroid hormones, 170-estradiol or progesterone, may play with respect to the 6/15ax-hydroxylase ratio was next evaluated.
Gonadectomy (55) . We hypothesized that the antiandrogenic activity of the vinclozolin metabolites should block both the suppressive effect of testosterone on 6a-OH activity and its inductive effect on 1 5a-OH activity, resulting in an increase in the 6a/15at-OH ratio. Vinclozolin treatment of male mice resulted in the induction of both 6a-OH and 15a-OH, which is consistent with a phenobarbital-type induction of hepatic P450s (Table 4) . However, the 6a/15a-OH ratio was significantly increased in the vinclozolin-treated mice, indicative of "demasculinization." Thus, the 6Wa/15a-OH ratio was successful as a biomarker of exposure to an antiandrogen. Indole-3-carbinol treatments. I3C proved to be an effective modulator of serum testosterone levels. Treatment of male CD-1 mice with I3C resulted in a dose-dependent, although highly variable, decrease in serum testosterone levels when compared to male controls (Fig. 4A) . A statistically significant decrease in serum testosterone, however, was only obtained at the highest dosage of 13C, 750 mg/kg/day. The 6a/lSa-OH ratio increased as serum testosterone levels decreased (Fig. 4B) , demonstrating the inverse relationship between serum testosterone and the 6a/15ox-OH ratio (Fig. 4C) . Notably, the 6a/15oa-OH ratio at each dosage was much less variable than the serum testosterone levels seen in the animals; a statistically significant increase in the ratio could be detected at a lower dosage (500 mg/kg/day) of I3C ( Fig. 4B ).
Discussion
Results from this study demonstrate that the testosterone 6W/ 1 5a-OH ratio can serve as a sensitive biomarker of androgen disruption in CD-1 mice and is a more powerful measure of androgen status within the animal than direct analysis of serum testosterone levels. Circulating testosterone levels in male (31, 61, 63) . In addition, the variability in testosterone levels in samples collected from the same animals on different occasions is comparable to the variation between individuals bled on a single occasion (31) .
Our results indicate that the testosterone 6Wa/15ac-OH ratio provides a more powerful and sensitive measure of androgen status in CD-1 mice. In contrast to the variability reported in serum testosterone concentrations of control mice, CVs of the 6/ 1 5ax-OH ratio ranged from only 1.6% to 31%. When mice were dosed with 13C, a compound that modulated steroid hormone levels, a statistically significant difference in testosterone levels could only be achieved at the highest dosage, 750 mg/kg/day. A significant difference in the 6W/ 1 5a-OH ratio could be detected at a lower dosage, 500 mg/kg/day. Therefore, the 60c/1 5-OH ratio was not only less variable but also a more sensitive measure of androgen status. The ratio provides insight into the average androgen status of the organisms rather than a snapshot of androgen levels at the time of sampling. The 6a/15ax-OH ratio not only detects effects of the chemical on endogenous androgen levels but also responds to antiandrogenicity of a chemical. Antiandrogens would not be expected to lower serum testosterone levels, but would interfere with the functions of testosterone. The use of this biomarker will greatly enhance the ability to detect androgendisrupting chemicals in assays involving CD-1 mice.
It appears that the 6Wx/15ax-OH ratio cannot be universally applied to all species, however. Little information is available regarding sexual dimorphisms in testosterone biotransformation activity or androgen regulation of these activities in other species. Sexual dimorphisms of testosterone hydroxylase activity are best documented in the rat. For example, hepatic microsomal testosterone 7ac-OH activity is expressed in both sexes, but its expression is female-predominant (42) . Testosterone 2ac-, 20-, 6 ,-, and 16a-OH activities have been reported to be higher in male rats than in female rats (64) . Sexual dimorphisms in hepatic metabolism of testosterone have been described in hamsters (65) , birds (66,6;7) , and fish (68, 69) , but particular sex-specific differences in hepatic testosterone hydroxylase activities vary with species. Whether testosterone biotransformation profiles could be used as biomarkers of androgen disruption in other species has not been thoroughly explored and would probably require the development of different metabolic ratios applicable to the species of interest.
In humans, epidemiological study of testosterone levels has been limited due to interindividual variability (70, 71) . While the interindividual variability in humans is not as great as that seen in mice, the normal serum testosterone values in mature adult males range, depending upon the testing method, from a low of 1.8 to a high of 18.4 ng/ml (72) . The interindividual variability is confounded by intraindividual variations in serum testosterone values. Both circadian and circannual fluctuations in circulating androgen levels within individuals have been reported (73) (74) (75) (76) . In addition, several other factors have been isolated that appear to be negatively correlated with serum testosterone levels; these include age (70, 77, 78) , weight (70, 79) , smoking (70, 80) , and alcohol ingestion (81, 82) . Thus, a study using testosterone levels in men as an end point for endocrine disruption would have to control for several confounding factors.
Like male and female CD-1 mice, male and female humans appear to produce the same androgen metabolite profiles (83) .
Preliminary studies in our lab, however, indicate that sex differences may exist in the rates of production of certain metabolites in humans as well. Characterization of these sex differences may allow for the development of metabolic ratios that could be used as indicators of androgen disruption in humans. Because it has been demonstrated that individual steroid metabolites may be eliminated in and can be isolated from human urine, the potential exists for the development of diagnostic immunoassays for the determination of such metabolites (87) . Once a pertinent ratio is identified in humans, androgen disruption can then be assessed noninvasively by assay of urine samples.
